Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2. (2021)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/jitc-2020-002140
PubMed Identifier: 34112739
Publication URI: http://europepmc.org/abstract/MED/34112739
Type: Journal Article/Review
Volume: 9
Parent Publication: Journal for immunotherapy of cancer
Issue: 6
ISSN: 2051-1426